Daré Bioscience Inc.

3.00
0.03 (1.01%)
At close: Apr 23, 2025, 3:59 PM
3.09
3.17%
After-hours: Apr 23, 2025, 07:31 PM EDT
1.01%
Bid 2.9
Market Cap 26.51M
Revenue (ttm) 9.78K
Net Income (ttm) -4.05M
EPS (ttm) -0.48
PE Ratio (ttm) -6.24
Forward PE -2.25
Analyst Buy
Ask 3.23
Volume 10,225
Avg. Volume (20D) 23,175
Open 3.00
Previous Close 2.97
Day's Range 2.99 - 3.01
52-Week Range 2.67 - 7.56
Beta 1.34

About DARE

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its produc...

Industry Biotechnology
Sector Healthcare
IPO Date Apr 10, 2014
Employees 21
Stock Exchange NASDAQ
Ticker Symbol DARE
Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for DARE stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 334.06% from the latest price.

Stock Forecasts
8 months ago
+20%
Dare Bioscience shares are trading higher after th... Unlock content with Pro Subscription
8 months ago
+3.24%
Dare Bioscience shares are trading higher. The company reported Q2 financial results.